Yet, it also casts a shadow
While GLP-1 drugs may offer neuroprotective effects relevant to glaucoma, the impact of dual-incretin therapies like tirzepatide on glaucoma remains unknown
However, although many patients initially respond to androgen depletion therapy, they almost invariably relapse and develop resistance with transition of the disease to a castration-resistant state
Thus, to highlight possible application of pentadecapeptide BPC 157 in both IBD and multiple sclerosis patients, this study shows BPC 157's potential to counteract the consequences of the cuprizone application, used in an extremely high regimen that highly exceeds those commonly applied (62)
With this unmatched coverage, pharmaceutical manufacturers and healthcare researchers can move beyond traditional claims analysis to access verified insights that illuminate real-world treatment dynamics across diverse patient populations